“…BACKGROUND: Atractylenolide I (ATR-1), an active component of Rhizoma Atractylodis Macrocephalae, possesses cytotoxicity against various carcinomas. However, little is known about the effects of ATR-1on bladder cancer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Epithelial ovarian cancer is unique among most carcinomas in that metastasis occurs by direct dissemination of malignant cells traversing throughout the intraperitoneal fluid. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Individuals with BHD have multiple pulmonary cysts and are at a high risk for developing renal cell carcinomas (RCCs). Currently, little information is available about whether pulmonary cysts are absolutely benign or if the lungs are at an increased risk for developing neoplasms. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Histologically, 41% (7/17) of the successfully genotyped blocks were squamous cell carcinomas (larynx 6, maxillary sinus 1). RESULTS AND CONCLUSION: We were unable to detect HPV in any of the HNC samples in our study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In chemically induced bladder carcinomas, C4.4A deficiency attenuated the incidence of invasive lesions despite having no effect on total tumour burden. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The incidences of malignant mesothelioma and lung tumors (bronchiolo‐alveolar adenomas and carcinomas) were 6/38 and 14/38, respectively, in the three groups administered MWCNT and 0/28 and 0/28, respectively, in the control groups. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…S100A4 expression was analyzed by immunohistochemistry in primary colorectal carcinomas from a consecutively collected, population‐representative cohort and a randomized phase III study on adjuvant 5‐fluorouracil/levamisole. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Among the histological subtypes the lowest gene expression levels of ESR1, PGR and PRLR were found in solid, anaplastic and ductal carcinomas. In summary, the evaluation showed that the measurement of hormone receptors with the multiplex bDNA assay represents a practicable method for obtaining detailed quantitative information about gene expression in canine mammary tissue for future studies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BRAF fusions included 3% (14/531) of melanomas; 2% (15/701) of gliomas; 1.0% (3/294) of thyroid cancers; 0.3% (3/1,062) pancreatic carcinomas; 0.2% (8/4,013) nonsmall‐cell lung cancers and 0.2% (4/2,154) of colorectal cancers, and were enriched in pilocytic (30%) vs. nonpilocytic gliomas (1%; p < 0.0001), Spitzoid (75%) vs. nonSpitzoid melanomas (1%; p = 0.0001), acinar (67%) vs. nonacinar pancreatic cancers (<1%; p < 0.0001) and papillary (3%) vs. nonpapillary thyroid cancers (0%; p < 0.03). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Our data provides rationale for potential combinations of erlotinib and immunotherapies for the treatment of lung carcinomas in the early setting, before the establishment of tumor relapse with long-term EGFR inhibition.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Thirty-two patients with advanced cervical squamous cell carcinomas underwent diffusion weighted magnetic resonance imaging (b values, 0 and 800 s/mm(2)) before CCRT, at the end of 2nd and 4th week during CCRT and immediately after CCRT completion. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Compared with Caucasian patients, the Chinese patients had a later year of diagnosis, remained married after EC was diagnosed, had esophageal squamous cell carcinomas (ESCCs) more frequently, had tumors located in the upper-third and middle-third of the esophagus more frequently, and fewer patients presented with poorly/undifferentiated EC and underwent cancer-directed surgery. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…They can be classified according to pathological, radiological or clinical behaviour as typical, atypical or carcinomas, invasive or noninvasive, and aggressive or nonaggressive. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: ESD was performed in 225 patients with 261 lesions, including 70 cases (26.8%) of dysplasias and 191 cases (73.2%) of squamous cell carcinomas. The median age was 65 years (range, 44 to 86), and the male to female ratio was 21.5:1. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cisplatin is a classic chemotherapeutic agent widely used to treat different types of cancers including ovarian, head and neck, testicular and uterine cervical carcinomas. However, cisplatin induces acute kidney injury by directly triggering an excessive inflammatory response, oxidative stress, and programmed cell death of renal tubular epithelial cells, all of which lead to high mortality rates in patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…These are overexpressed in many carcinomas, and high expression of these molecules is a risk factor associated with poor prognosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Investigation of occupational and environmental CAuses of REspiratory cancers (ICARE), a French population-based case–control study, included 296 squamous cell carcinomas of the head and neck (HNSCC) in women and 775 female controls. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Risk factors for esophageal carcinomas include obesity, gastroesophageal reflux disease, hard-alcohol use and tobacco smoking. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Taken together, our results suggest that TA modulates EGF‐R/Jak2/STAT1/3 and P38/STAT1/p21(Waf1/Cip1) pathways and induce G1‐arrest and intrinsic apoptosis in breast carcinomas.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Inhibitors targeting epigenetic control points of oncogenes offer a potential mean of blocking tumor progression in small cell and non-small cell lung carcinomas (SCLC, NSCLC). OTX015 (MK-8628) is a BET inhibitor selectively blocking BRD2/3/4. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso